Loading...
Galapagos N.V.
GLPG•NASDAQ
Healthcare
Biotechnology
$32.65
$1.80(5.83%)
Galapagos N.V. (GLPG) Financial Performance & Income Statement Overview
Review Galapagos N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
14.99%
↑ 14.99%
Operating Income Growth
-113.38%
↓ 113.38%
Net Income Growth
-65.01%
↓ 65.006%
Operating Cash Flow Growth
21.17%
↑ 21.17%
Operating Margin
-111.44%
↓ 111.44%
Gross Margin
50.30%
↑ 50.30%
Net Profit Margin
-58.83%
↓ 58.83%
ROE
-5.94%
↓ 5.94%
ROIC
-8.96%
↓ 8.96%
Galapagos N.V. (GLPG) Income Statement & Financial Overview
Review Galapagos N.V.'s (GLPG) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $74.98M | $75.50M | $59.85M | $77.87M |
| Cost of Revenue | $13.73M | $15.74M | $19000.00 | $16.56M |
| Gross Profit | $61.25M | $59.76M | $59.83M | $61.32M |
| Gross Profit Ratio | $0.82 | $0.79 | $1.00 | $0.79 |
| R&D Expenses | $182.75M | $97.19M | $93.05M | $73.61M |
| SG&A Expenses | $43.80M | $3.69M | $46.58M | $33.14M |
| Operating Expenses | $219.96M | $122.48M | $114.14M | $106.75M |
| Total Costs & Expenses | $233.69M | $138.22M | $114.15M | $123.31M |
| Interest Income | $12.56M | $17.22M | $23.13M | $23.71M |
| Interest Expense | $780000.00 | -$499000.00 | $695000.00 | $285000.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $5.86M | $4.28M |
| EBITDA | -$158.71M | $19.13M | -$48.45M | $4.97M |
| EBITDA Ratio | -$2.12 | $0.25 | -$0.81 | $0.06 |
| Operating Income | -$158.71M | -$62.72M | -$54.30M | -$45.43M |
| Operating Income Ratio | -$2.12 | -$0.83 | -$0.91 | -$0.58 |
| Other Income/Expenses (Net) | $2.34M | $81.75M | $5.16M | $42.27M |
| Income Before Tax | -$156.37M | $19.03M | -$49.14M | $4.09M |
| Income Before Tax Ratio | -$2.09 | $0.25 | -$0.82 | $0.05 |
| Income Tax Expense | -$1.81M | -$93000.00 | -$571000.00 | -$571000.00 |
| Net Income | -$153.40M | $25.31M | -$50.43M | $8.98M |
| Net Income Ratio | -$2.05 | $0.34 | -$0.84 | $0.12 |
| EPS | -$2.33 | $0.29 | -$0.77 | $0.14 |
| Diluted EPS | -$2.33 | $0.38 | -$0.77 | $0.14 |
| Weighted Avg Shares Outstanding | $65.84M | $87.55M | $65.90M | $65.90M |
| Weighted Avg Shares Outstanding (Diluted) | $65.84M | $66.03M | $65.90M | $65.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan